Ro vs. Hims for GLP-1: How the Two Telehealth Programs Compare

Ro runs a membership model: its weight-loss program is advertised at roughly $45 for the first month, then about $145/month, with the cost of GLP-1 medication billed separately and dependent on the specific treatment and any insurance coverage (provider-attributed, verify current). Ro emphasizes brand-name GLP-1s — including Wegovy, Ozempic, and Zepbound — and also lists an oral form of Wegovy (a semaglutide pill).

For cash-pay shoppers, Ro publishes Zepbound single-dose vial prices, commonly cited starting around $299/month for the 2.5mg starter dose, with higher doses in the roughly $399–$449/month range, on top of the ongoing membership (provider-attributed, verify current). Ro notes it will not coordinate insurance coverage for GLP-1 medications with certain government-funded plans such as Medicare or Tricare. As with any prescription program, access begins with a consultation with a licensed provider.

Hims & Hers advertises a lower published entry point. Its oral weight-loss kits start as low as about $69/month on prepaid plans, and its injectable GLP-1 plans start from around $199/month on prepaid terms (provider-attributed, verify current). In March 2026, Hims announced an agreement with Novo Nordisk to offer brand-name GLP-1 medicines — including Ozempic and both the injectable and pill forms of Wegovy — to U.S. consumers at prices the company says match other telehealth firms; brand oral Wegovy via Novo Nordisk self-pay is cited from about $149/month (provider-attributed, verify current).

Like Ro, Hims requires evaluation by a licensed provider before any prescription is written. The medication you are ultimately offered, and your total cost, depend on the clinical consultation, the plan term you choose, and the specific medication.

The right fit depends on what you value. Ro may appeal if you prefer a clear membership structure and published cash-pay vial pricing for brand-name options like Zepbound. Hims & Hers may appeal if a lower advertised starting price matters and you want brand Wegovy (including the pill) through its Novo Nordisk partnership.

Two practical notes. First, prepaid or annual terms drive the lowest advertised numbers at both companies — confirm the total commitment, not just the monthly figure, at checkout. Second, neither program is the only option. If flat, all-inclusive cash pricing or compounded medication is a priority, it can be worth comparing both against an independent provider such as ShedRx, which lists compounded semaglutide and tirzepatide starting around $199/month and also offers brand Wegovy and Zepbound (per ShedRx-referenced review pricing — verify current pricing at the source). Whichever route you consider, the medication itself still requires a consultation with a licensed provider.

For adults 18+. Prescription medications require a consultation with a licensed provider. This is not medical advice. Statements have not been evaluated by the FDA. GLP-1 medications discussed here — including semaglutide and tirzepatide, and brand names such as Ozempic, Wegovy, Zepbound, and Mounjaro — are prescription medications. This article is educational and does not endorse obtaining any prescription without a licensed provider's evaluation. Prices are starting points or typical ranges published by each provider and may change at any time; confirm current pricing and program terms directly with the provider.